Ex Parte Petersen - Page 36


             Appeal No. 2006-0704                                                            Page 36                
             Application No. 10/060,697                                                                             

             bone paste that contains thermally crosslinkable gelatin[ ]41  as the carrier for one or more             
             osteogenic components.”  Id.  According to appellants (Brief, page 9), Wironen                         
             “specifically contrasts the teachings therein with a commercialized embodiment                         
             [(GRAFTON)] of the formulation described in the O’Leary reference.”  However, upon                     
             closer inspection of Wironen, I find that the reference discloses (page 3, lines 22-26):               
                    one commercially available product, GRAFTON®, (see U.S. Patent No.                              
                    5,484,601) is a non-cross-linkable composition of demineralized bone                            
                    powder suspended in a polyhydroxy compound (e.g. glycerol) or esters                            
                    thereof, optionally including various other ingredients, including gelatin.                     
                    It is considered likely that this material is rapidly washed away from the                      
                    implant location as the carrier matrix is glycerol, which is water soluble.                     
                    As I understand appellants’ argument, Wironen recognizes a “disadvantage” of                    
             one embodiment of O’Leary.  I note, however, that “[a]ll the disclosures in a reference                
             must be evaluated . . . a reference is not limited to the disclosure of specific working               
             examples.”  In re Mills, 470 F.2d 649, 651, 176 USPQ 196, 198 (CCPA 1972).  In this                    
             regard, I note that O’Leary does teach that glycerol, as well as a number of other                     
             agents, may be used as a carrier.  See, e.g., O’Leary, column 3, lines 36-55.  Further,                
             O’Leary recognizes the problem noted by Wironen when glycerol is used as the carrier.                  
             See O’Leary, column 3, line 63 – column 4, line 7, emphasis added,                                     
                    where [for example] the carrier component is glycerol and separation of                         
                    bone powder occurs to an excessive extent where a particular application                        
                    is concerned, a thickener such as . . . hydroxypropyl methylcellulose . . .                     
                    can be combined with the carrier in an amount sufficient to significantly                       
                    improve the suspension-keeping characteristics of the composition.                              


                                                                                                                    
             41 Thermally cross-linkable gelatin is a preferred embodiment of Wironen’s disclosure.  See, e.g., page 7,
             lines 16-25, “[t]he composition of this invention comprises gelatin. . . .  The gelatin is preferably thermally
             cross-linkable. . . .”  In this regard, I remind appellants that a reference is not limited to its preferred
             embodiments.                                                                                           





Page:  Previous  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  Next 

Last modified: November 3, 2007